A tiny drug delivery device that fits in the eye, still under development in California, could help glaucoma patients who do not comply with drug treatment schedules, according to a report by EuroTimes.
In addition to addressing non-compliance, the device can address ocular surface problems caused by eye drops and other systemic effects of the drugs, said the device's developer, Rohit Varma, MD, professor of ophthalmology at Doheny Eye Institute at the University of Southern California.
Addressing the World Glaucoma Congress in Vienna, Dr. Varma said the new device is about the size of an Ahmed implant and should be commercially available in three to five years.
Read the EuroTimes report on the drug-delivery device for glaucoma patients.
Related Articles on Glaucoma:
Study: Glaucoma Drugs May Reduce Mortality Risk
New Minnesota Ophthalmology Surgery Center Set to Open in Blaine
Florida ASC Receives AAAHC Accreditation